Tysabri Injection
Product Images NDC 64406-008

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tysabri (NDC 64406-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tys00 0069 01)

A line graph comparing the proportion of patients with sustained increase in disability over time on therapy in weeks between TYSABRI (natalizumab) and placebo groups. The graph shows lower disability increase in the TYSABRI group (17%) compared to placebo (29%), with a statistically significant p-value less than 0.001.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Label for TYSABRI (natalizumab) injection, 300 mg per 15 mL (20 mg/mL) single-dose vial. The label includes usage directions for intravenous infusion, storage instructions to refrigerate at 2-8°C (36-46°F), warnings not to freeze and to protect from light, and notes to discard unused portion. Manufactured by Biogen Inc., Cambridge, MA, USA, with NDC 64406-008.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Carton label for TYSABRI (natalizumab) injection, 300 mg/15 mL (20 mg/mL), for intravenous infusion, requiring dilution prior to use. Label includes storage instructions to refrigerate at 2-8°C and protect from light, along with manufacturer information (Biogen Inc., Cambridge, MA). The label also lists vial contents and excipients, pharmacist attention notice, and features barcodes and QR code area for product tracking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.